Resultados de la búsqueda 491-500 of 70390 for Treatment

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers. Rochester, Minn. The purpose of this study is to determine the response ...

2. Radiología - Ensayos clínicos - Mayo Clinic

   ... treatment. Actinium Therapy For Late-stage Aggressive Sarcomas. Rochester, Minn. The goal of this clinical trial is to learn about the safety of drug \[Ac225 ...

3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... treatment monitoring in patients with metastatic breast cancer. A Study to Compare the Cosmetic Outcome of Superomedial and Inferior Pedicle Breast ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as ...

5. Oncología (médica) - Ensayos clínicos

   Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... treatment monitoring in patients with metastatic breast cancer. A Study to Compare the Cosmetic Outcome of Superomedial and Inferior Pedicle Breast ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This part will collect information on the leukemia, as well as the effects of the initial treatment, in order to classify patients into post-consolidation ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...